(19)
(11) EP 4 568 616 A2

(12)

(88) Date of publication A3:
02.05.2024

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23853506.6

(22) Date of filing: 09.08.2023
(51) International Patent Classification (IPC): 
A61F 2/07(2013.01)
A61L 31/00(2006.01)
A61F 2/86(2013.01)
(52) Cooperative Patent Classification (CPC):
A61F 2/07; A61F 2002/075; A61F 2250/0067; A61F 2002/9528
(86) International application number:
PCT/US2023/071910
(87) International publication number:
WO 2024/036199 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.08.2022 US 202263396492 P
09.08.2022 US 202263396552 P

(71) Applicant: The General Hospital Corporation
Boston, MA 02114 (US)

(72) Inventors:
  • SINGH, Varun
    Boston, MA 02114 (US)
  • GASTON, Brandon
    Boston, MA 02114 (US)

(74) Representative: Maiwald GmbH 
Engineering Elisenhof Elisenstrasse 3
80335 München
80335 München (DE)

   


(54) ENDOVASCULAR BIOLOGIC STENT